J.P. Morgan Private Equity has completed its offering of 2015 zero dividend preference shares.  As the offering was oversubscribed, the company has closed on its maximum target of GBP30,000,000. The Company resolved to issue an aggregate of 53,333,333 2015 ZDP Shares at a price of 56.25p per share, representing a

NBGI Private Equity has backed a GBP13m management buy in of Pasta King UK, which provides pasta meals to schools and other sectors. The business has been acquired from its incumbent management and Matrix Private Equity Partners. Pasta King, which is based in Newton Abbot, Devon, provides meal solutions comprising

Numis Securities believes that now is the time to buy listed private equity funds, particularly those that can still be acquired on a significant discount. It believes the outlook for realisations is improving and there is scope for net asset values to rise due to higher earnings multiples in quoted

Triodos Renewables is launching a share issue to raise up to GBP7m which will be invested directly in renewable energy projects. The share issue is only open to existing shareholders and new investors making investments of over GBP50,050. With 15 years’ experience in the field, Triodos Renewables currently operates five

A group of venture capital firms has completed the sale of its stakes in Proteolix, a biopharmaceutical company, to Onyx Pharmaceuticals. The group is comprised of Nomura Phase4 Ventures, Westfield Capital Management, Advanced Technology Ventures, Delphi Ventures, Latterell Venture Partners, US Venture Partners and The Vertical Group . Onyx is

Focus Financial Partners, a partnership of independent wealth management firms, has received a USD50m growth capital investment from Polaris Venture Partners and Summit Partners. Polaris has contributed USD35m and Summit, Focus’ initial backer in January 2006, an additional USD15m. Concurrent with the investment, Focus has extended and amended its bank

Institutions and financial advisers continue to view alternative investments optimistically, despite their questionable performance, correlation and liquidity during last year’s global downturn, according to a survey by Morningstar and Barron’s. The majority of participants to the survey said they plan to increase allocations to alternatives, but with greater scrutiny and

Bain Capital has signed definitive agreement to acquire Citigroup’s controlling stake in Japan’s call centre operator, BellSystem24, in a tender offer valuing the company at approximately JPY100bn (USD1.1bn). Bain Capital has received committed financing for the transaction from Japan’s largest banks – Sumitomo Mitsui Banking, The Bank of Tokyo-Mitsubishi UFJ

CambridgeSoft has completed a private equity investment by Health Evolution Partners and a follow-on investment by Goldman Sachs. CambridgeSoft is a supplier of discovery, collaboration, and knowledge management research IT enterprise solutions, desktop software, scientific databases and consulting services for the pharmaceutical, biotechnology, and chemical industries. Health Evolution chairman David